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Abstract Aging is accompanied by troubles resulting from 
changes in hormonal and nutritional status. Therefore, the 
abundance of mRNA coding for triiodothyronine (TR) and 
retinoic acid (RA) nuclear receptors was studied in the brain of 
young, adult and aged (2.5, 6 and 24 months, respectively) rats. 
In the brain of aged rats, there was a lower abundance of TR and 
RAR mRNA and a lower activity of tissue transglutaminase 
(tTG), an enzyme the gene of which is a target for retinoids. 
Administration of RA in these rats restored TR and RAR mRNA 
and the activity of tTG in the brain. The importance of these 
observations to the function of the aged brain is discussed. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The brain is particularly affected by aging and the neuro-
anatomical changes observed in aged animals include nerve 
cell loss, dendritic spines reduction, and modification of syn-
aptic plasticity. Among age-related diseases, some result from 
modifications in hormonal status such as a decrease in respon-
siveness to hormones, as well as a deficit of transcription and 
translation of certain messengers [1]. Aging affects thyroid 
function inducing, first, a decrease in the rate of hormone 
degradation and, second, via negative feedback loops, a de-
crease in the secretory rate of the hormone so that the serum 
level of triiodothyronine (T3) is slightly reduced or unaltered 
[2,3]. 
Vitamins can also be involved in the development of prob-
lems during aging. Indeed, several physiological and biochem-
ical modifications can alter the vitamin status and changes in 
availability of vitamins can have a drastic effect when these 
vitamins are able to modulate genie transcription, such as in 
the case of vitamin A [4,5]. Retinoic acid (RA), which is the 
active metabolite of vitamin A, and T3 mediate their effects by 
modulating the expression of specific genes through binding to 
specific nuclear receptors which are transcription factors 
(RAR and TR, respectively). Moreover, signaling pathways 
of retinoids and thyroid hormones interplay and recent studies 
indicate that heterodimeric nuclear receptors utilize several 
mechanisms for increasing the complexity of transcriptional 
response [6]. 
Several years ago, RA [7] and T3 [review in [8]] were estab-
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lished to be indispensable for the development of the central 
nervous system of vertebrates. Then, it was demonstrated that 
TR is expressed in numerous regions of the adult rat brain [9]. 
More recently it has been shown that the adult brain synthe-
tizes RA, suggesting that retinoids may play an important role 
in the adult central nervous system [10]. The brain exhibits a 
selective distribution of cellular retinoid-binding proteins [11] 
and of nuclear receptors [12]. Among the RAR, RAR[3 is the 
main isoform expressed in the mature brain and this receptor 
is up-regulated by RA. It has been suggested that RARp is 
involved in physiological functions and that these functions 
are regulated by RA concentration in the adult brain [12]. 
Thus, the roles of RA and T3 in the developing, as well as 
the adult brain, are now established but there is little data 
concerning the involvement of these hormones in the aged 
brain. The aim of this investigation, therefore, was to study 
the influence of aging on the expression of RAR and TR in 
rat brain. The abundance of RAR and TR mRNA was meas-
ured and the activity of tissue transglutaminase (tTG) was 
assayed because the gene coding for this enzyme is regulated 
by retinoids, so that the enzymatic activity is considered to be 
an indicator of retinoid action [13,14]. Finally, the effect of 
administration of RA or retinyl palmitate (RP) (24 h before 
killing) in rats (6 or 24 months old) on RAR and TR mes-
sengers and enzymatic activity was studied. 
2. Materials and methods 
2.1. Experimental design 
Official French regulations for the care and use of laboratory ani-
mals were followed. Weanling male Wistar rats were obtained from 
IFFA CREDO (L'Arbresle, France). Rats were housed four to a cage, 
in an air-conditioned room with a mean temperature of 21 °C and a 
photoperiod which followed the seasonal pattern. Rats were randomly 
divided into seven groups designated as Young, Adult, Aged, 
Adult+RP, Adult+RA, Aged+RP and Aged+RA. Young rats were 
studied at 10 weeks of age, adult rats at 6 months and aged rats at 
24 months. Adult+RA and Adult+RP were adult rats treated with 
5 mg of retinoic acid (n\\-trans RA; Sigma no. R 2625)/kg body 
weight or 13 mg of retinyl palmitate (Sigma no. R 3375)/kg body 
weight, respectively, using an intragastric intubation 24 h before being 
killed. Aged+RP and Aged+RA were aged rats treated as Adult+RP 
and Adult+RA, respectively. Rats were fed a semi-synthetic diet pre-
pared by the 'Atelier de preparation d'aliments experimentaux' (In-
stitut National de la Recherche Agronomique INRA, 78350 Jouy en 
Josas, France) according to published recommendations on the feed-
ing conditions of laboratory animals [15] and contained 8 000 UI 
vitamin A/kg. Food and water were freely available. Body weights 
were recorded throughout the experiment. Rats were killed by decap-
itation (between 09:00 and 10:00 h) and the brains were rapidly re-
moved and stored at —80°C for subsequent analysis (mRNA quanti-
fication and cytosol preparation). 
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Fig. 1. Relative quantification of RAR and TR transcripts in rat brain. A: RT-PCR products resolved on the 10% acrylamide gel electrophore-
sis and stained with ethidium bromide. Lane 1, co-amplification of B-actin, RAR and TR transcripts in rat brain. Lane 2, molecular size 
markers 0X174/hinfI. B: Semi-logarithmic representation of the relative extent of amplification (Y) measured by counting the amount of 
[a32P]dCTP incorporated; R is the PCR efficiency. 
2.2. Quantification of mRNA 
mRNA was quantified by reverse transcription and amplification by 
the polymerase chain reaction (RT-PCR). The values of RAR and TR 
mRNA were obtained by comparison with levels of an internal stand-
ard, B-actin, that was simultaneously reverse-transcribed and ampli-
fied in the same test tube. The constancy of the level of B-actin 
mRNA with aging [16] was verified in our experimental conditions 
using the PCR MIMIC™ Construction Kit (Clontech Laboratories, 
Palo Alto, CA). Moreover, it is known that RA administration does 
not affect B-actin mRNA [17]. The conditions of extraction of mRNA, 
preparation of cDNA, amplification and quantitative analysis of PCR 
products have been described elsewhere [18]. The determination of the 
proportion of RAR and TR mRNA to B-actin mRNA was calculated 
according to Chelly and al. [19]. The oligonucleotide primers for 
RARB, TRal and (31 (messengers encoding for proteins which bind 
T3) are described in Table 1. Primers were purchased from GENSET 
(Paris, France). Fig. 1 shows, as an example, the results of an electro-
phoresis of PCR products of rat transcripts of /3-actin, TR and RAR 
genes and also, a semi-logarithmic representation of the relative extent 
of am 
rated. 
2.3. Tissue transglutaminase assay 
Brain homogenates (30%, w/v) for the tTG assay were prepared in 
50 mM Tris-HCl buffer (pH 7.0) containing 0.25 M sucrose and 1 mM 
EDTA. After centrifugation at 105 000 Xg for 60 min, the supernatant 
was collected for enzyme assay which was performed by detecting the 
incorporation of [3H]putrescine into JV,JV'-dimethylcasein according to 
the method of Piacentini et al. [23]. 
Table 1 
Sequences of oligonucleotide primers and size of amplified fragments 
Primers Sequences Complementary sites Size of amplified fragments(bp) 
B-actina 
RARb 
T R c 
Al 
A2 
Rl 
R2 
El 
E2 
AGGATGCAGAAGGAGATTACTGCC 
GTAAAACGCAGCTCAGTAACAGTCC 
CTCACTGAGAAGATCCGGAAAGCCCACC 
TTGGTGGCCAGCTCACTGAATTTGTCCC 
TCCTGATGAAGGTGACGGACCTGC 
TCAAAGACTTCCAAGAAGAGAGGC 
2814-2837 
3159-3135 
538- 565 
680- 653 
1247-1270 
1364-1341 
222 
143 
118 
aFrom rat cytoplasmic /3-actin gene according to the sequence of Nudel et al. [20]. 
bFrom murine RAR cDNA according to the sequence of Zelent et al. [21]. 
cFrom rat TR cDNA according to the sequence of Murray et al. [22]. 
Primers Al and A2 were chosen in two different exons, the size of the PCR products provided a means to verify that the amplified fragment was 
not derived from genomic DNA. 
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Table 2 
Influence of aging on the abundance of retinoic acid (RAR) and triiodothyronine (TR) nuclear receptor mRNA and on tissue transglutammase 
activity (tTG) in whole rat brain 
6 months 24 months 
RAR mRNA 3.5± 0.1 3.4± 0.1 
(ARAR/AR 
—actin 
TR mRNA 4.9 ± 0.2 3.3 ± 0.2C 
(ATR/Ap_arfiin %)" 
tTG activity 180 ± 10 188 ±20 
(fmol/h/mg prot.)b 
"Data represent the mean values ± SEM from 4 different pools of 2 rats. 
bData represent the mean values ± SEM from 8 rats. 
Significantly different from (c) 2.5- or (d) 6-month-old rats (ANOVA followed by Tukey's multiple range post hoc test). 
2.6 ± 0.1c'd 
2.6 ± 0.2 c'd 
118 ±10c-d 
3. Results 
3.1. Effect of aging on TR and RAR abundance 
Table 2 shows that in the brain of aged rats (24 months old) 
the amounts of RAR and TR mRNA were lower (—26 
and —47%, respectively) than in the brain of young rats 
(2.5 months). Moreover, the tTG activity was reduced in the 
brain of aged rats by approximately 34% relative to young 
rats. In the adult rats (6 months old), a lower amount (—32%) 
of TR mRNA was observed. 
3.2. Effect of retinyl palmitate or retinoic acid administration 
3.2.1. Adult (6 months old) rats. Twenty-four hours after 
RP administration, the abundance of TR and RAR mRNA 
and the tTG activity were not affected. On the other hand, 
after RA administration the amount of TR mRNA increased 
by about 20% and that of RAR mRNA by about 30% 
(Table 3). 
3.2.2. Aged (24 months old) rats. RP administration had 
no effect on the abundance of TR mRNA while an increased 
RAR mRNA content (+30%) was observed. Following RA 
administration increased amounts of RAR and TR mRNAs 
(approximately +40%) and an increased tTG activity (+115%) 
were observed. 
4. Discussion 
The lower amount of TR mRNA in the brain of aged rats is 
in agreement with the results of De Nayer et al. [24] showing a 
decreased maximum binding capacity of TR in the brain of 
aged rats. The present data demonstrate, moreover, that this 
decreased expression of TR in aged animals resulted, at least 
in part, from a transcriptional event. This finding could be 
related to results obtained in Alzheimer cases (disease re-
garded as a pathological form of aging) showing a decreased 
level of TR mRNA, particularly of the sub-type TRa, in 
Alzheimer hippocampus [25]. Data on the influence of T3 in 
the regulation of expression of 77? genes are few but it has 
been shown that 77? genes have a positive responsiveness to 
T3 administration [26], and that thyroid hormone up-regulates 
77?/? gene expression in rat cerebral hemisphere astrocyte cul-
tures [27]. Such data suggest that the decreased expression of 
the 77? gene in aged brain may result from a reduction of the 
bioavailability of T3 at the nuclear level. 
The lower abundance of RAR(3 mRNA observed in the 
brain of aged rats may be considered to be the result of either 
a decreased RA bioavailability (which becomes insufficient to 
ensure the up-regulation of RAR|3 by RA), or an inability of 
RA to up-regulate its own receptors in a deficient T3 status. It 
is known that, when T3 is deficient, TR without ligand (apo-
receptors) blocks the activity of RAR [28]. A decreased ex-
pression of RAR in the liver of hypothyroid rats has previ-
ously been reported [26,29]. 
The decreased activity of tTG, an enzyme the gene of which 
is a target of retinoids, is in agreement with the decreased 
abundance of RARP mRNA. The lower expression of tTG 
in old rats may have neurobiologic consequences. Indeed, it is 
known that this Ca2+-dependent enzyme induces covalent 
cross-linking of neuronal, probably dendritic, proteins and 
that such a binding mechanism may be part of the long-
term potentiation process (LTP) [30]. The LTP synaptic trans-
mission is used as an experimental model for investigating the 
synaptic basis of learning and memory [review in [30]]. 
In a second part of this study, acute treatment with RA or 
RP was used to investigate restoration of youthful levels of 
mRNA of these nuclear receptors in aged rats. In aged rats, 
24 h after RA administration, increased abundances of RAR 
as well as TR mRNA were observed. These results demon-
strate that the expression of RAR and 77? genes, in the brain, 
which decreases with age, can be up-regulated by RA as in 
Table 3 
Effect of retinyl palmitate (RP) or retinoic acid (RA) administration on RAR and TR mRNA abundance and on tissue transglutammase (tTG) 
activity in the brain of 6- (adult) or 24-month-old (aged) rats 
RAR mRNA 
(ARAR/AR_actin %)" 
TR mRNA 
(ATR/AB 
—actin tTG activity 
(fmol/h/mg/prot.)b 
Adult rats 
Basal 
3.4 ± 0.1 
3.3 ± 0.2 
188 ±16 
+RP 
3.4 ± 0.2 
3.0 ± 0.2 
152 ±20 
+RA 
4.4 ± 0.4* 
4.0 ± 0.2* 
214 ±16 
Aged rats 
Basal 
2.7 ± 0.1 
2.6 ± 0.2 
118 ±12 
+RP 
3.5 ± 0.3* 
2.9 ± 0.2 
160 ±14 
+RA 
3.8 ± 0.1* 
3.7 ± 0.1* 
254 ±12* 
aData represent the mean values ± SEM from 4 different pools of 2 rats. 
bData represent the mean values ± SEM from 8 rats. 
'Significantly different from non-treated old rats (ANOVA followed by Tukey's multiple range post hoc test). 
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adult rats. Moreover, tTG activity, which is a good indicator 
of RA action [13,14], and which is low in aged rats, is also 
induced by RA. The observation of an up-regulation of TR 
mRNA by RA in the brain of aged rats constitutes an addi-
tional example of interaction between the signaling pathways 
of RA and T3. The influence of vitamin A status on TR 
expression in the liver has previously been shown [31]. The 
mechanism responsible for this kind of heteroregulation of 
TR transcription has not been established but RXR (nuclear 
receptor the ligand of which is the 9-cis RA isomer) may be 
involved because TR and RAR form heterodimers with the 
common partner RXR [32]. 
The dose of RP used had no apparent effect on adult rats 
but was able to induce an up-regulation of RAR in aged rats 
(whose RAR mRNA abundance is lower). Thus, in the con-
ditions of this study, the responsiveness of RAR to RP ad-
ministration would seem to depend on the level of receptor 
expression. RA induced an increase in RAR mRNA abun-
dance in aged rats but also in adult rats because RA is a 
more potent retinoid than RP. 
In summary, we showed that RAR and TR genes, which are 
involved during the development of the brain, are under-ex-
pressed in the older brain but this level of expression can be 
restored by retinoid administration. New studies are required 
to identify the molecular targets of RA and T3 and particu-
larly the genes for which RAR and TR are transcription fac-
tors. The present study confirmed that tTG is modulated by 
RA but there are numerous putative proteins which could also 
be neuronal targets for RA and T3 in the aged brain. Among 
these proteins, it will be interesting to study a neuronal spe-
cific protein, RC3 (neurogranin), because this protein is under 
the influence of thyroid hormone in vivo [33] and because a 
RA response element (RARE) has been described in its gene 
[34]. RC3 is related to dendritic spine formation and synaptic 
plasticity so that it could be hypothesized that in the aged 
brain a deficiency of T3 and/or RA expression is responsible 
for a low level of RC3 and subsequently for a deficient syn-
aptic plasticity. 
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